Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Royalty Pharma (RPRX) Stock Price & Analysis
439 Followers
RPRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$32.68 - $44.24
Previous Close$34.64
Volume2.29M
Average Volume (3M)1.79M
Market Cap
$21.03B
Enterprise Value$29.62B
Total Cash (Recent Filing)$2.43B
Total Debt (Recent Filing)$7.12B
Price to Earnings (P/E)306.8
Beta0.21
Next Earnings
May 04, 2023EPS Estimate
$0.83Last Dividend Ex-Date
Feb 15, 2023Dividend Yield
0.77 (2.17%)Share Statistics
EPS (TTM)0.11
Shares Outstanding443,166,030
10 Day Avg. Volume1,974,350
30 Day Avg. Volume1,794,491
Standard Deviation0.07
R-Squared0.09
Alpha-0.00724
Financial Highlights & Ratios
Price to Book (P/B)2.98
Price to Sales (P/S)7.50
Price to Cash Flow (P/CF)7.70
P/FCF Ratio9.30
Enterprise Value/Market CapN/A
Enterprise Value/Revenue13.24
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda69.91
Forecast
1Y Price Target
$47.67Price Target Upside34.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Royalty Pharma News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RPRX FAQ
What was Royalty Pharma PLC’s price range in the past 12 months?
Royalty Pharma PLC lowest stock price was $32.68 and its highest was $44.23 in the past 12 months.
What is Royalty Pharma PLC’s market cap?
Currently, no data Available
When is Royalty Pharma PLC’s upcoming earnings report date?
Royalty Pharma PLC’s upcoming earnings report date is May 04, 2023 which is in 44 days.
How were Royalty Pharma PLC’s earnings last quarter?
Royalty Pharma PLC released its earnings results on Feb 15, 2023. The company reported $1.558 earnings per share for the quarter, beating the consensus estimate of $1.472 by $0.086.
Is Royalty Pharma PLC overvalued?
According to Wall Street analysts Royalty Pharma PLC’s price is currently Undervalued.
Does Royalty Pharma PLC pay dividends?
Royalty Pharma PLC pays a Quarterly dividend of $0.2 which represents an annual dividend yield of 2.17%. See more information on Royalty Pharma PLC dividends here
What is Royalty Pharma PLC’s EPS estimate?
Royalty Pharma PLC’s EPS estimate is $0.83.
How many shares outstanding does Royalty Pharma PLC have?
Royalty Pharma PLC has 443,166,020 shares outstanding.
What happened to Royalty Pharma PLC’s price movement after its last earnings report?
Royalty Pharma PLC reported an EPS of $1.558 in its last earnings report, beating expectations of $1.472. Following the earnings report the stock price went down -0.291%.
Which hedge fund is a major shareholder of Royalty Pharma PLC?
Among the largest hedge funds holding Royalty Pharma PLC’s share is Viking Global Investors LP. It holds Royalty Pharma PLC’s shares valued at 396M.
---
Royalty Pharma Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$47.67 (34.74% Upside)
$47.67 (34.74% Upside)
Blogger Sentiment
Bullish
RPRX Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 829.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $931.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days >0.1%
Last 30 Days ▲ 6.0%
Last 30 Days ▲ 6.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.27%
12-Months-Change
Fundamentals
Return on Equity
0.75%
Trailing 12-Months
Asset Growth
-4.01%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Royalty Pharma PLC
New York-based Royalty Pharma Plc is a biopharmaceutical company, which is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
---
---